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Background: Uvaria chamae is a medicinal plant that is used in many parts of the world in 
the treatment of diabetes, and other diseases. However, research is needed to ascertain the 
beneficial and adverse effects of the consumption of the extract. In this study, we evaluated the 
acute and subchronic oral toxicity and safety of the aqueous root extract of Uvaria chamae in 
Sprague-Dawley rats. Methods: In the phase one of the acute toxicity study, the aqueous 
extract of the root was administered in single doses of 10, 100 and 1000 mg/kg body weight. In 
the phase two, the extract was administered in single doses of 600, 2900 and 5000 mg/kg body 
weight.  In the sub-chronic toxicity study, the extract was administered at doses of 200, 500, 
1000, 2000, 3000 and 5000 mg/ kg body weight/day for 28 days. Results: The acute toxicity 
study showed the LD50 of the extract to be above 5000 mg/kg body weight. In the subchronic 
toxicity study, oral administration of the extract induced a significant (p < 0.05) increase in 
monocytes count and platelets. There was a significant increase (p<0.05) in AST at 5000 
mg/kg compared to the other concentrations administered. At 2000 mg/kg of extract the ALT 
level was significantly (p<0.05) elevated compared to control and the lower concentrations, 
while the ALP was significantly (p<0.05) reduced at the doses of 200, 500, 1000, and 2000 
mg/kg when compared to control and the other concentrations. There were no significant 
changes in total protein and albumin at the different doses of the extract. Moreover, the Uvaria 
chamae extract did not significantly alter kidney function parameters such as creatinine, BUN, 
Na+, K+, HCO3- and Cl- in comparison to control. Histopathological evaluation showed mild 
vascular congestion and infiltrates of lymphocytes in the liver and kidney. We also noted well-
formed islet cells of Langerhans in rats administered doses ≤ 1000 mg/kg body weight of the 
extract. Conclusion: Data from the study showed that the consumption of the extract at any 
level in the management of diseases may have potential health benefits for the management of 
anemia.  
 .  
 
INTRODUCTION1  
Uvaria chamae (P. Beauv), commonly called Awuloko 
or Ayiloko by the I+gala people, or Oko aja or Eruju by 
the Yorubas or Kas Kaifi by the Hausas in Nigeria, 
grows naturally in the savannah and rain forest regions 
of Africa and tropical areas of the world. It is also 
commonly known as finger root or bush banana and  









belongs to the family Annonaceae. It is an evergreen 
plant which grows to a height of 3.6 – 4.5 m. The fruits 
are yellow when ripe and have a sweet pulp which is 
widely eaten. All parts of the plant are fragrant with 
wide spread medicinal use among traditional West 
African medicine practitioners. The leaves are eaten as 
vegetables. Uvaria chamae stem ashes are used as salt 
substitute in food. The leaf juice is applied to wounds, 
sores, ulcers and cuts while the leaf infusion is used to 
treat injuries, swellings, ophthalmia irritis and 
conjunctivitis. The root-decoction is used as a purgative 
and lotion, and for the treatment of piles, menorrhagia, 
epistaxis, hematuria and hemolysis (Omajali et al., 
2011). Sap from the root and stem is applied to wounds 
and sores, and the root is made into a drink and body-
wash for edematous condition (Burkill, 1985). The root 
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bark yields an oleo-resin that is taken internally for 
catarrhal inflammation of mucous membranes, 
respiratory catarrh and gonorrhea. The root infusion is 
used to cure abdominal pains (Omajali et al., 2011). In 
folk medicine, extracts of the root, bark and leaves are 
used to treat gastroenteritis, malaria fever, vomiting, 
diarrhea, wounds, sore throat and inflamed gums 
(Okwu, 2003). Uvaria chamae users commonly add 
one tablespoonful of pulverized root sample in a cup of 
hot or warm tea or pap (akamu amongst 
the Igbo and Ogi or Akamu amongst the Yorubas in 
Nigeria) - a traditional porridge made 
from ground maize twice daily. One tablespoonful of 
the pulverized sample is equivalent to about 333 mg of 
the aqueous extract.  It has been reported that Uvaria 
chamae has hypoglycaemic, antifungal, bacteriostatic 
and antimalaria properties (Onoagbe et al.,1999; 
Okokon et al., 2006; Ogbulie et al., 2007; Okwuosa et 
al., 2012). The root of Uvaria chamae has also been 
reported to contain C-benzylated monoterpenes, 
aromatic oils (Lasswell and Hufford, 1977), flavanones, 
C-benzylated flavanones (Hufford and Lasswell 1976), 
and C-benzylated dihydrochalcones (Lasswell and 
Hufford, 1977). Despite the wide spread use of Uvaria 
chamae, in traditional medicine, toxicological data on 
the plant are scarce. This study was carried out to 
assess the acute and subchronic toxicity studies of the 
aqueous root extract of Uvaria chamae in Sprague 
Dawley rats, with the purpose of providing information 
on the safety of this widely use medicinal plant.  
 
MATERIALS AND METHODS 
Plant material and extraction  
Fresh root pieces of wild Uvaria chamae grown in 
Igwo, Oyo state of Nigeria and harvested in 2012 was 
purchased from the herbal market, at Oyingbo, in 
Lagos, Nigeria. The root pieces were identified and 
authenticated by a taxonomist at the department of 
Plant Biology and Biotechnology, Faculty of Life 
Sciences, University of Benin, Benin City, Nigeria as 
root of Uvaria chamae. A voucher specimen of the 
plant with reference number UBH 266 has been 
deposited in the University’s Plant Biology and 
Biotechnology Department Herbarium. The plant roots 
were thoroughly washed, cut into small pieces and sun 
dried. A mechanical grinder was used to grind the roots 
into a uniform powder (pulverization). The pulverized 
sample was kept in a bowl and soaked in distilled 
water. The water level was about 2 cm above the 
sample layer; there was intermittent stirring to allow for 
percolation and maceration. This process continued for 
72 hours to allow for effective extraction (Onoagbe and 
Esekheigbe 1999). After 72 hours, the sample was 
filtered using a cheese cloth, and the filtrate was further 
filtered with Buchner’s funnel, freeze dried (3720 g of 
plant material + 26.4 liters of distilled water yielded 
167 g after extraction and freeze drying i.e. 167 g 
aqueous extract = 3720 g dried Uvaria Chamae root), 
and stored in the freezer.   
 
Animals 
Sprague Dawley rats were purchased from the 
Department of Anatomy, University of Benin, Benin 
City, Nigeria. The animals were housed in clean cages 
under standard laboratory conditions of temperature, 
humidity and light. They had free access to standard 
laboratory diet and distilled water for a period of two 
weeks for acclimatization. Approval for the study was 
obtained after presentation of the protocol to the Board 
of the Department of Biochemistry, University of 
Benin, Benin City, Nigeria. 
 
Acute oral toxicity  
 The method as described by Lorke (1983) was used for 
the acute toxicity study. In this method there are two 
phases: phase I requires 3 animals per group, while 
phase II requires one animal per group. In this study, 
twelve (12) Sprague Dawley (average body weight 
156.46 ± 3.1 g) rats were used.  In the first phase 
(Phase I) of the extract administration, nine rats were 
divided into 3 groups of 3 rats each. The set of animals 
in the 3 groups were administered 10 mg, 100 mg, and 
1000 mg/kg body weight of extract respectively. After 
an overnight fast, animals were observed before the 
administration of a single dose of the extract using an 
oral gastric gavage. After dosing, food was withheld for 
about 2 hours to prevent asphyxia or regurgitation, and 
the animals were observed individually during the first 
30 minutes, and then 2, 4, 6, 24 and 48 hours after 
treatment. The observation focused on mortality, 
changes in behavior, skin, eyes, fur and somatomotor 
activity. In the second phase (Phase II), three specific 
doses were chosen based on the results of the first 
phase. They were divided into 3 groups of one rat per 
group: group 1A (1600 mg/kg body weight of the 
extract); group 2A (2900 mg/kg body weight of the 
extract); and group 3A (5000 mg/kg body weight of the 
extract). After an overnight fast, animals were observed 
before the administration of a single dose of the extract. 
They were observed for 24 hours for signs of toxicity 
and mortality.  
 
Subchronic oral toxicity 
Forty-two (42) Sprague Dawley rats were used for this 
study and grouped according to sex and weight 
(average body weight 195.66 ± 4.70 g). Animals were 
divided into 7 groups (6 rats in each group) as follows: 
group 1 received distilled water; group 2 received 200 
mg/kg body weight of the extract; group 3 received 500 
mg/kg body weight of the extract; group 4 received 
1000 mg/kg body weight of the extract; group 5 
received 2000 mg/kg body weight of the extract; group  
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Table 1. Effect of the extract on liver enzymes in Sprague Dawley rats 
 
 
6 received 3000 mg/kg body weight of the extract; and 
group 7 received 5000 mg/kg body weight of the 
extract. The animals in all the groups were fasted 
overnight and observed before the administration of the 
extract. The extract was administered using an oral 
gastric gavage once a day (between 8.00 a.m. – 9.00 
a.m.) for 28 days. Groups 2 - 7 received 200, 500, 
1000, 2000, 3000, and 5000 mg/kg body weight of the 
extract dissolved in distilled water. The animals were 
observed for signs of toxicity and mortality daily 
throughout the experimental period. Observations 
included visual and auditory responses, movements, 
respiration, skin and hair coat, salivation, lacrimation, 
diarrhea, and response to proprioceptive stimulus. 
Neurological observations included tactile response and 
response to tail pinch, locomotor and equilibrium.  On 
the 28th day, the animals were fasted overnight, 
euthanized by decapitation and blood collected for 
hematological assessment (blood collected in EDTA 
tubes) and biochemical assays (blood collected in tubes 
without anti-coagulants). Laparotomy was performed 
on the animals and organs were immediately collected 
for histopathological evaluation. 
 
 
Fig. 1: Effect of oral administration of different doses of the 
extract on serum proteins in Sprague Dawley rats. Serum 
concentrations of total protein and albumin in the liver were 
expressed as mean ± SEM. Values were not significantly 
different among the groups (𝑃 > 0.05). 
Blood Analysis 
Serum lactate dehydrogenase (LDH), total protein, 
albumin, alanine amino transferase (ALT), aspartate 
amino transferase (AST), alkaline phosphatase (ALP), 
amylase, blood urea nitrogen (BUN), electrolyte and 
creatinine were determined using VITROS® DT 60 11 
chemistry system. The system uses VITROS DT slides 
to perform a number of discreet clinical tests on serum 
or plasma specimen. All reactions needed for a single 
quantitative measurement take place within the 
multilayered analytical element of the slide. The unique 
properties of these slides permit reliable analyses with a 
very small volume of sample. All processes performed 
by the analyzer are controlled by a self-contained 
microcomputer. The communication with the 
microcomputer is through the keyboard, which 
communicates with the user through messages that 
appear on the display screen and print outs. 
Manufacturer: KNAUER. GMI SKUN#: 8195-10-0020 
model. For hematological analysis, white blood cell 
count, lymphocyte, monocytes, granulocytes, red blood 
cell (RBC), packed cell volume, hemoglobin (Hgb), 
mean corpuscular volume (MVC), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC), platelets were determined 
using PCE-210N (full automatic Blood cell counter). 
 
Histopathological examination 
Isolated organ tissues were fixed in 10% solution of 
buffered formalin (pH 7.4) followed by dehydration 
and then embedded in paraffin wax. The organs were 
sectioned and stained with hematoxylin and eosin 
(H&E) prior to microscopic examination. 
 
Statistical analysis 
Data are expressed as mean ± standard error of the 
mean (S.E.M.) one-way ANOVA with Duncan’s 
multiple range test performed to assess differences 
between groups (SPSS 21.0 for Windows). Values of p 
< 0.05 were considered statistically significant.  
 
RESULTS 
Acute toxicity; Clinical observations 
 Apart from monitoring toxicity by mortality, other 
means of doing so include lacrimation, refusal of feed, 
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diarrhoea, paralysis, bleeding from the nose, mouth, or 
genitals, changes in the skin, fur, eyes mucous 
membrane, salivation, and tremors. However, in phases 
I and II in this study none of the above mentioned 
indices of toxicity were observed. At the end of the 48 
hours’ observation in the phase I and phase II of the 
acute toxicity study, there was no mortality in any of 
the groups or treatment-related signs of toxicity, and no 
death was recorded at 5000 mg/kg body weight of the 
extract administration.  So, the LD50 value of the 
extract by oral administration was greater than 5000 
mg/kg body weight. The method described by Lorke 
(1983) was used to determine the acute toxicity of the 
extract.  
 
Sub-chronic oral toxicity; Clinical observations 
Following a single treatment with the extract in the 
acute toxicity study, no exterior signs of toxicity were 
observed. Daily oral administration of the extract at 
doses of 200, 500, 1000, 2000, 3000 and 5000 mg/kg 
/body weight for 28 days did not induce any obvious 
symptoms of toxicity and mortality in the rats.   
 
 
Fig. 2. Effect of oral administration of different doses of the 
extract on serum amylase in Sprague Dawley rats. Serum 
concentrations of amylase were expressed as mean ± SEM. 
*P < 0.05 is significant compared to control. 
 
Biochemical assessment 
We noted significant decrease (p < 0.05) in serum LDH 
and ALP activities in animals administered 200, 500, 
1000, and 2000 mg of the extract compared to the 
control group (Table 1). 
 
 Fig. 3. Effect of oral administration of different doses of the 
extract on kidney function test in Sprague Dawley rats. 
Serum concentrations of BUN and creatinine were expressed 
as mean ± SEM. Values are not significantly different among 
the groups (𝑃 > 0.05). 
 
 
Total protein and albumin levels were not significantly 
(p > 0.05) altered in the groups treated with the extract 
compared to the control group (Figure 1).  There was a 
significant decrease (p < 0.05) in serum amylase 
activity in the group treated with 5000 mg of the extract 
compared to the control group (Figure 2). The levels of 
serum electrolytes assayed were not significantly (p > 
0.05) altered in the groups treated with the extract 
compared to the control group (Table 2). We did not 
observe any significant changes in the levels of serum 
BUN and creatinine in animals treated with the extract 
compared to the control group (Figure 3).  
 
Repeated daily oral administrations of the extract at 
200, 500, 1000, 2000, 3000 and 5000 mg/kg body 
weight for 28 days. Serum concentrations of LDH, 
AST, ALT, ALP were expressed as mean ± SEM. 
Values in the same row with different superscripts are 
significantly different at p < 0.05. LDH, lactate 
dehydrogenase; AST, aspartate amino transferase; 
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Table 2. Effect of oral administration of different doses of the extract on serum electrolytes in Sprague Dawley rats 
 
Serum concentrations of Na+, K+, Cl-, and HCO3- were expressed as mean ± SEM. Values were not significantly 
different among the groups (𝑃 > 0.05). 
 
 
Table 3. Effect of oral administration of different doses of the extract on white blood cells, platelets and 
differentials in Sprague Dawley rats 
 
Concentrations of WBC, LY, MO, GR, and Platelets were expressed as means ± SEM. Values in the same row with 
different superscripts are significantly different at P < 0.05. Abbreviations: WBC, white blood cell; LY, 
lymphocyte; MO, monocyte; GR, granulocyte. 
 
Table 4. Effect of oral administration of different doses of the extract on Red Cell Indices in Sprague Dawley rats 
 
 
Concentrations of RBC, Hgb, PCV, MCV, MCH, and 
MCHC were expressed as mean ± SEM. Values are not 
significantly different among the groups (𝑃 > 0.05). 
Abbreviations: MCV, mean corpuscular volume; MCH,  
 
mean corpuscular hemoglobin; MCHC, mean 
corpuscular hemoglobin concentration; Hgb, 
hemoglobin; PCV, pack cell volume; RBC, red blood 
cell. 
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The white blood cells and platelets were not 
significantly (p > 0.05) altered in rats treated with the 
extract. There was a significant (p < 0.05) increase in 
the monocytes levels in rats administered 2000 and 
3000 mg/kg of the extract compared to the control 
group (Table 3). The red cell indices were not 
significantly (p > 0.05) altered in the treatment groups 
versus the control group (Table 4).  
 
Histopathological analysis 
The liver of rats treated with the extract showed mild 
portal vascular congestion, mild periportal infiltrates of 
lymphocytes when compared to the control group 
(Plates 1, 2, 3, 4, 5 and 6). Similarly, we also noted 
mild interstitial vascular congestion and dilatation, and 
mild infiltrates of lymphocytes in the kidney of rats 
treated with the extract compared to the control group 
(Plates 7, 8, 9, 10, 11 and 12). However, in the 
pancreas, treatment with the extract showed well-
formed islets and normal exocrine glands at doses ≤ 
1000 mg/kg body weight compared to the control group 
(Plates 13, 14, 15, 16, 17 and 18). 
 
 
Fig. 6.  Photomicrograph of section of rat liver after 28 days 
of treatment with the extract at doses of 200, 500, 1000, 2000 
and 5000 mg/kg body weight/day (plates 2-6 respectively) as 
compared to the control (plate1). There is vascular 
congestion [A] and periportal infiltrates of lymphocytes [B] 
in plates (2-6). Sections were stained with H&E X 400 
(plates 1-6). 
 
Fig. 7. Photomicrograph of section of rat kidney after 28 
days of treatment with the extract at doses of 200, 500, 1000, 
2000 and 5000 mg/kg body weight/day (plates 8-12 
respectively) compared to the control (plate 7). There is mild 
interstitial vascular congestion [A] and edema [B] and mild 
infiltrates of lymphocytes [C] in plates (8-12). Sections were 
stained with H&E X 400 (plates 7-12). 
 
DISCUSSION 
In this study, we presented a comprehensive safety 
evaluation of the aqueous root extract of Uvaria 
chamae by performing acute and subchronic toxicity 
studies in Sprague Dawley rats. In the acute toxicity 
study, no animal died within 24 hours of the 
administration of the extract.  Lorke (1983) suggested 
that LD50 > 5000 mg/kg body weight is thought to be 
safe. Similarly, according to the acute toxicity grading 
standards (Duan and Liang, 2011; Aniagu, 2005), if the 
LD50 is greater than 5000 mg/kg, the drug is considered 
as practically non-toxic. The LD50 of Uvaria chamae 
aqueous extract was found to be higher than 5000 
mg/kg.  The absence of death among the rats in all the 
doses administered seems to support this claim. Hence, 
the oral administration of the aqueous extract of Uvaria 
chamae can be said to be practically non-toxic.  
Subchronic toxicity studies have been reported to be 
valuable in evaluating the safety of xenobiotics (Hodge, 
1949). In the 28 days subchronic oral toxicity study, 
animals of both sexes were used. We did not observe 
any death in the groups administered the extract. 
Daily.oral administration of the extract for 28 days ced 
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Fig. 8. Photomicrograph of section of rat pancreas after 28 
days of treatment with the extract at doses of 200, 500, 1000, 
2000 and 5000 mg/kg body weight/day (14-18 respectively) 
as compared to the control (13). There were well formed 
islets [A], normal exocrine glands [B] and mild vascular 
congestion [C]). Sections were stained with H&E X 400 (13-
18) 
 
Induced a significant (p < 0.05) increase in AST and a 
reduction in ALT at the dose of 5000 mg/kg body 
weight when compared to the control group. The 
cellular enzymes ALT and AST are present in low 
concentrations in serum under normal conditions. 
Increased synthesis of the enzymes or leakage from 
damaged cells may elevate enzyme concentrations in 
serum (Burtis and Ashwood, 1999; Pincus and 
Schaffner, 1996). Hepatic impairment may also affect 
serum protein concentration (Burtis and Ashwood, 
1999). Elevated serum AST and ALT levels are 
commonly used as sensitive markers of possible tissue 
damage, particularly liver damage (Ramaiah, 2007). 
Acute or chronic injury of the liver causes the elevation 
of the enzyme activities in the bloodstream (Han et al., 
2011; Ozer et al., 2008). The observed changes in AST 
and ALT levels in the blood of animals administered 
the extract was dose dependent. The consumption of 
low doses of the extract (< 5000 mg/kg body weight) 
may not adversely affect liver function.  
There were no significant changes in serum creatinine, 
BUN and electrolytes levels among the groups. This 
may be indicative of no adverse effect of the extract on 
renal function since the elevation of creatinine in the 
serum has been reported to be associated with marked 
failure of nephron function (Lameire et al., 2005).  In 
the histological examination, we noted well-formed 
islets and normal exocrine glands. The observed 
enhancing effect of the extract on the pancreatic cells 
may partly explain the traditional use of the plant 
extract in the management of diabetes.  
Hematopoietic system has been reported to be one of 
the most sensitive targets for toxic substances (Harper, 
1973). The oral administration of the extract induced a 
significant (p < 0.05) increase in monocytes count at 
the tested doses of 2000 and 3000 mg/kg when 
compared to the control group. Although these changes 
may be indicative of adverse hematological changes at 
the respective doses, but it may also be suggestive of 
the extract possessing immune-stimulatory potentials, 
since the observed alterations were not reflected in 
other related parameters investigated at similar doses. 
However, our histopathological data showed that the 
extract may have some active ingredients that provoked 
the immune system to produce the lymphocytes seen in 
the renal interstitial space and the Kupffer cells lining 
the sinusoids of the liver. Further studies are needed to 
determine whether the infiltration of the lymphocytes 
into the kidney and liver will be beneficial or have 
adverse consequences.  
The goal of the subchronic evaluation was to establish a 
‘no observed adverse effect level’ NOAEL and to 
identify the specific organ or organs that are affected by 
the extract after repeated exposure. Overall, our data 
shows that the liver, kidney and pancreas are possible 
targets of extract consumption. While the aqueous 
extract consumption at ≤ 1000 mg/kg body weight may 
accrue health benefits through the enhancement of the 
pancreatic cells, the liver and kidney revealed immune 
boosting activity by the extract as there was ‘no 
observed adverse effect level’ for the extract.  
 
CONCLUSION 
The oral dose of the extract administered did not 
produce acute toxicity in Sprague Dawley rats. Hence, 
its single oral dose of LD50 for rats is in excess of 5000 
mg/kg body weight. In the 28 days subchronic oral 
toxicity study, we established ‘no observed adverse 
effect level’ for the extract. The consumption of the 
extract (≤ 1000 mg/kg body weight) enhanced the 
pancreatic tissues, and provoked the local immune 
systems of the liver and kidney. Further studies are 
needed to determine the key ingredients responsible for 
the acclaimed traditional therapeutic applications of the 
root extract in the management of diseases.  
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